vs
安捷伦科技（A）与Wellgistics Health, Inc.（WGRX）财务数据对比。点击上方公司名可切换其他公司
安捷伦科技的季度营收约是Wellgistics Health, Inc.的1076.2倍（$1.8B vs $1.7M）。安捷伦科技净利率更高（17.0% vs -1667.2%，领先1684.2%）
安捷伦科技是全球知名的生命科学、诊断与应用化学领域解决方案提供商，旗下生命科学与应用市场业务板块提供液相色谱系统及组件、液相色谱质谱联用系统、气相色谱设备、电感耦合等离子体质谱仪、原子吸收仪等多种分析检测仪器，服务全球各领域客户。
Wellgistics Health, Inc.是一家总部位于美国的医疗服务企业，主营处方药物、非处方药品及医疗用品的分销业务，服务对象包括零售药房、长期护理机构及各类独立医疗服务提供者。
A vs WGRX — 直观对比
营收规模更大
A
是对方的1076.2倍
$1.7M
净利率更高
A
高出1684.2%
-1667.2%
损益表 — Q1 2026 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $1.8B | $1.7M |
| 净利润 | $305.0M | $-27.9M |
| 毛利率 | 52.6% | -470.2% |
| 营业利润率 | 19.6% | -1517.5% |
| 净利率 | 17.0% | -1667.2% |
| 营收同比 | 7.0% | — |
| 净利润同比 | -4.1% | — |
| 每股收益（稀释后） | $1.07 | $-0.24 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AWGRX
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.9B | $1.7M | ||
| Q3 25 | $1.7B | $3.0M | ||
| Q2 25 | $1.7B | $7.8M | ||
| Q1 25 | $1.7B | $10.9M | ||
| Q4 24 | $1.7B | — | ||
| Q3 24 | $1.6B | — | ||
| Q2 24 | $1.6B | — |
净利润AWGRX
| Q1 26 | $305.0M | — | ||
| Q4 25 | $434.0M | $-27.9M | ||
| Q3 25 | $336.0M | $-34.3M | ||
| Q2 25 | $215.0M | $-6.7M | ||
| Q1 25 | $318.0M | $-32.4M | ||
| Q4 24 | $351.0M | — | ||
| Q3 24 | $282.0M | — | ||
| Q2 24 | $308.0M | — |
毛利率AWGRX
| Q1 26 | 52.6% | — | ||
| Q4 25 | 53.2% | -470.2% | ||
| Q3 25 | 51.1% | 7.7% | ||
| Q2 25 | 51.9% | 6.5% | ||
| Q1 25 | 53.5% | 6.4% | ||
| Q4 24 | 53.9% | — | ||
| Q3 24 | 54.2% | — | ||
| Q2 24 | 54.4% | — |
营业利润率AWGRX
| Q1 26 | 19.6% | — | ||
| Q4 25 | 23.8% | -1517.5% | ||
| Q3 25 | 20.7% | -1047.1% | ||
| Q2 25 | 18.0% | -70.6% | ||
| Q1 25 | 22.4% | -288.6% | ||
| Q4 24 | 24.0% | — | ||
| Q3 24 | 21.1% | — | ||
| Q2 24 | 23.1% | — |
净利率AWGRX
| Q1 26 | 17.0% | — | ||
| Q4 25 | 23.3% | -1667.2% | ||
| Q3 25 | 19.3% | -1139.0% | ||
| Q2 25 | 12.9% | -85.6% | ||
| Q1 25 | 18.9% | -298.5% | ||
| Q4 24 | 20.6% | — | ||
| Q3 24 | 17.9% | — | ||
| Q2 24 | 19.6% | — |
每股收益（稀释后）AWGRX
| Q1 26 | $1.07 | — | ||
| Q4 25 | $1.53 | $-0.24 | ||
| Q3 25 | $1.18 | $-0.46 | ||
| Q2 25 | $0.75 | $-0.11 | ||
| Q1 25 | $1.11 | $-0.62 | ||
| Q4 24 | $1.23 | — | ||
| Q3 24 | $0.97 | — | ||
| Q2 24 | $1.05 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.8B | $42.6K |
| 总债务越低越好 | $3.0B | $23.5M |
| 股东权益账面价值 | $6.9B | $-12.4M |
| 总资产 | $12.8B | $30.5M |
| 负债/权益比越低杠杆越低 | 0.44× | — |
8季度趋势，按日历期对齐
现金及短期投资AWGRX
| Q1 26 | $1.8B | — | ||
| Q4 25 | $1.8B | $42.6K | ||
| Q3 25 | $1.5B | $4.2M | ||
| Q2 25 | $1.5B | $419.9K | ||
| Q1 25 | $1.5B | $2.5M | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.8B | — | ||
| Q2 24 | $1.7B | — |
总债务AWGRX
| Q1 26 | $3.0B | — | ||
| Q4 25 | $3.0B | $23.5M | ||
| Q3 25 | $3.4B | $24.8M | ||
| Q2 25 | $3.3B | $23.3M | ||
| Q1 25 | $3.3B | $24.1M | ||
| Q4 24 | $3.3B | — | ||
| Q3 24 | $2.1B | — | ||
| Q2 24 | $2.1B | — |
股东权益AWGRX
| Q1 26 | $6.9B | — | ||
| Q4 25 | $6.7B | $-12.4M | ||
| Q3 25 | $6.4B | $6.8M | ||
| Q2 25 | $6.1B | $905.3K | ||
| Q1 25 | $6.0B | $4.5M | ||
| Q4 24 | $5.9B | — | ||
| Q3 24 | $5.9B | — | ||
| Q2 24 | $6.2B | — |
总资产AWGRX
| Q1 26 | $12.8B | — | ||
| Q4 25 | $12.7B | $30.5M | ||
| Q3 25 | $12.2B | $52.8M | ||
| Q2 25 | $12.2B | $54.2M | ||
| Q1 25 | $11.9B | $58.1M | ||
| Q4 24 | $11.8B | — | ||
| Q3 24 | $11.0B | — | ||
| Q2 24 | $10.9B | — |
负债/权益比AWGRX
| Q1 26 | 0.44× | — | ||
| Q4 25 | 0.45× | — | ||
| Q3 25 | 0.53× | 3.66× | ||
| Q2 25 | 0.55× | 25.72× | ||
| Q1 25 | 0.56× | 5.39× | ||
| Q4 24 | 0.57× | — | ||
| Q3 24 | 0.36× | — | ||
| Q2 24 | 0.34× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $268.0M | $-6.3M |
| 自由现金流经营现金流 - 资本支出 | $175.0M | — |
| 自由现金流率自由现金流/营收 | 9.7% | — |
| 资本支出强度资本支出/营收 | 5.2% | — |
| 现金转化率经营现金流/净利润 | 0.88× | — |
| 过去12个月自由现金流最近4个季度 | $993.0M | — |
8季度趋势，按日历期对齐
经营现金流AWGRX
| Q1 26 | $268.0M | — | ||
| Q4 25 | $545.0M | $-6.3M | ||
| Q3 25 | $362.0M | $-1.1M | ||
| Q2 25 | $221.0M | $-2.1M | ||
| Q1 25 | $431.0M | $-1.3M | ||
| Q4 24 | $481.0M | — | ||
| Q3 24 | $452.0M | — | ||
| Q2 24 | $333.0M | — |
自由现金流AWGRX
| Q1 26 | $175.0M | — | ||
| Q4 25 | $452.0M | — | ||
| Q3 25 | $259.0M | — | ||
| Q2 25 | $107.0M | — | ||
| Q1 25 | $334.0M | — | ||
| Q4 24 | $388.0M | — | ||
| Q3 24 | $360.0M | — | ||
| Q2 24 | $230.0M | — |
自由现金流率AWGRX
| Q1 26 | 9.7% | — | ||
| Q4 25 | 24.3% | — | ||
| Q3 25 | 14.9% | — | ||
| Q2 25 | 6.4% | — | ||
| Q1 25 | 19.9% | — | ||
| Q4 24 | 22.8% | — | ||
| Q3 24 | 22.8% | — | ||
| Q2 24 | 14.6% | — |
资本支出强度AWGRX
| Q1 26 | 5.2% | — | ||
| Q4 25 | 5.0% | — | ||
| Q3 25 | 5.9% | — | ||
| Q2 25 | 6.8% | — | ||
| Q1 25 | 5.8% | — | ||
| Q4 24 | 5.5% | — | ||
| Q3 24 | 5.8% | — | ||
| Q2 24 | 6.5% | — |
现金转化率AWGRX
| Q1 26 | 0.88× | — | ||
| Q4 25 | 1.26× | — | ||
| Q3 25 | 1.08× | — | ||
| Q2 25 | 1.03× | — | ||
| Q1 25 | 1.36× | — | ||
| Q4 24 | 1.37× | — | ||
| Q3 24 | 1.60× | — | ||
| Q2 24 | 1.08× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
A
| Service Other | $525.0M | 29% |
| Chemicaland Energy Market | $422.0M | 23% |
| Agilent Cross Lab | $273.0M | 15% |
| Environmentaland Forensics Market | $177.0M | 10% |
| Food Market | $166.0M | 9% |
| Academiaand Government Market | $130.0M | 7% |
| Applied Markets | $98.0M | 5% |
WGRX
暂无分部数据
